The global bioprocess technology market is expected to grow at a significant CAGR of 8.2% during the forecast period. The growing competition in the biotechnology and biopharmaceutical industry coupled with the rising demand for innovative therapeutics owing to the rising prevalence of chronic diseases has led to increasing demand for bioprocess technology. Investment in the biopharmaceuticals industry coupled with the rising need for drugs and vaccines has propelled the market growth. For instance, according to CCI India, India is one of the major producers of generic drugs globally, and the pharmaceutical sector supplies over 50% of global demand for various vaccines, 40% of generic demand in the US, and 25% of all medicines in the UK.
Browse the full report description of “Global Bioprocess Technology Market Size, Share and Trends Analysis Report, By Product Type (Instruments (Bioprocess Analyzers, Gas Analyzer, Osmometers, Bioreactor, and Incubators), and Consumables and Accessories (Culture Media, and Reagents)), By Process (Batch, Fed-Bath, and Continuous Fermentation), By End-User (Biotechnology and Biopharmaceutical Companies, Research and Academic Institutions, and Others) Forecast 2022-2028” at https://www.omrglobal.com/industry-reports/bioprocess-technology-market
The key players are continuously focusing on the adoption of various strategic moves such as partnerships, new product launches, mergers and acquisitions, and collaborations, to remain competitive in the global market. For instance, in June 2021, Boyd Technologies has provided growth services to biomedical companies, to leverage product design and development. Boyd provides single-use bags and tube set assemblies used in the biotechnology application. These products are largely used in bioprocessing for drugs and therapies and medical device applications, such as blood, IV, and transfusion bags. Moreover, in December 2021, Lonza agreed to collaborate with Agilent to manufacture cell therapy and assess new critical quality attributes required for the release of the therapeutic to the patients.
Market Coverage
• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2021-2028
• Segment Covered-
o By Product Type
o By Process
o By End-User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape: Danaher Corp., Eppendorf SE, Sartorius AG, Thermo Fisher Scientific Inc., and Waters Corp.
Key questions addressed by the report
• What is the market growth rate?
• Which segment/region dominates the market in the base year?
• Which segment/region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
o Recovery Timeline
o Deviation from the pre-COVID forecast
o Most affected region/segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Bioprocess Technology Market Report by Segment
By Product Type
By Process
By End User
Global Bioprocess Technology Market by Region
North America
• US
• Canada
Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
• Middle East & Africa
• Latin America
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/bioprocess-technology-market